13D/13G Filings - Relay Therapeutics Inc. (RLAY)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-07-12
12:07 pm
Purchase
2021-07-0913GRelay Therapeutics, Inc.
RLAY
FMR LLC10,362,000
11.216%
5,599,762increase
(+117.59%)
Filing
History
2021-02-16
4:12 pm
Purchase
2020-12-3113GRelay Therapeutics, Inc.
RLAY
Third Rock Ventures III L.P.10,551,115
11.700%
10,551,115increase
(New Position)
Filing
History
2021-02-16
09:16 am
Purchase
2020-12-3113GRelay Therapeutics, Inc.
RLAY
SB INVESTMENT ADVISERS (UK) LTD27,904,963
31.000%
27,904,963increase
(New Position)
Filing
History
2021-02-08
10:31 am
Purchase
2021-02-0513GRelay Therapeutics, Inc.
RLAY
FMR LLC4,762,238
5.292%
4,762,238increase
(New Position)
Filing
History
Goto Prev, 0, 1